HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Rong Xiang Selected Research

1- (4- ((1H- pyrazolo(3,4- d)pyrimidin- 4- yl)oxy)- 2- fluorophenyl)- 3- (4- chloro- 3- (trifluoromethyl)phenyl)urea

12/2014A preclinical evaluation of a novel multikinase inhibitor, SKLB-329, as a therapeutic agent against hepatocellular carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Rong Xiang Research Topics

Disease

147Neoplasms (Cancer)
09/2022 - 06/2002
63Breast Neoplasms (Breast Cancer)
07/2022 - 07/2003
40Neoplasm Metastasis (Metastasis)
10/2021 - 12/2002
17Inflammation (Inflammations)
10/2022 - 04/2011
12Carcinoma (Carcinomatosis)
11/2019 - 12/2002
11Carcinogenesis
11/2021 - 11/2004
9Infections
01/2022 - 02/2010
9Hepatocellular Carcinoma (Hepatoma)
01/2019 - 05/2009
8Lung Neoplasms (Lung Cancer)
07/2022 - 04/2005
8Ovarian Neoplasms (Ovarian Cancer)
03/2022 - 08/2012
7Melanoma (Melanoma, Malignant)
01/2016 - 12/2002
6Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
07/2022 - 06/2004
6Psoriasis (Pustulosis Palmaris et Plantaris)
11/2020 - 09/2015
4Neurodegenerative Diseases (Neurodegenerative Disease)
01/2022 - 01/2017
4Allergic Rhinitis
11/2021 - 08/2015
4Triple Negative Breast Neoplasms
01/2020 - 05/2015
4Atherosclerosis
09/2015 - 05/2014
3Nasal Polyps (Nasal Polyp)
03/2022 - 01/2020
3Rhinosinusitis
03/2022 - 01/2020
3Fibrosis (Cirrhosis)
01/2022 - 08/2014
3Polydactyly (Polydactylism)
01/2022 - 01/2016
3Adenocarcinoma of Lung
03/2021 - 01/2016
3Hypertriglyceridemia
01/2020 - 04/2015
3Diarrhea
01/2020 - 10/2019
3Colorectal Neoplasms (Colorectal Cancer)
01/2019 - 08/2012
3Obesity
10/2018 - 01/2016
3Prostatic Neoplasms (Prostate Cancer)
05/2017 - 08/2011
3Necrosis
01/2016 - 06/2009
3Colonic Neoplasms (Colon Cancer)
01/2016 - 05/2003
2Pancreatic Neoplasms (Pancreatic Cancer)
03/2022 - 02/2015
2Food Hypersensitivity (Food Allergy)
01/2022 - 09/2020
2COVID-19
01/2022 - 11/2021

Drug/Important Bio-Agent (IBA)

33Proteins (Proteins, Gene)FDA Link
01/2022 - 05/2004
19VaccinesIBA
11/2021 - 12/2002
15Biomarkers (Surrogate Marker)IBA
01/2022 - 08/2012
14CateninsIBA
07/2022 - 01/2013
14asparaginylendopeptidase (legumain)IBA
01/2022 - 01/2006
14DNA VaccinesIBA
01/2013 - 12/2002
13Pharmaceutical PreparationsIBA
09/2022 - 01/2006
11Transcription Factors (Transcription Factor)IBA
01/2020 - 07/2003
9RNA (Ribonucleic Acid)IBA
10/2022 - 01/2014
9LigandsIBA
03/2021 - 06/2002
9Small Interfering RNA (siRNA)IBA
01/2021 - 01/2012
9MicroRNAs (MicroRNA)IBA
01/2021 - 11/2016
9Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2020 - 08/2006
8Messenger RNA (mRNA)IBA
10/2022 - 11/2004
8CytokinesIBA
01/2021 - 03/2007
7Interleukin-2 (IL2)IBA
10/2021 - 05/2004
7LipidsIBA
01/2021 - 11/2009
6Monoclonal AntibodiesIBA
01/2022 - 04/2011
6Cancer VaccinesIBA
09/2020 - 09/2011
6DNA (Deoxyribonucleic Acid)IBA
06/2019 - 05/2003
5IntegrinsIBA
01/2022 - 06/2002
5CollagenIBA
01/2022 - 07/2007
5AntigensIBA
01/2021 - 04/2008
5Firefly LuciferasesIBA
08/2014 - 07/2012
5AutoantigensIBA
04/2008 - 12/2002
4NucleotidesIBA
10/2022 - 10/2019
4EnzymesIBA
10/2022 - 06/2016
4Phosphotransferases (Kinase)IBA
01/2022 - 01/2018
4Carrier Proteins (Binding Protein)IBA
01/2022 - 01/2019
4Peptides (Polypeptides)IBA
01/2022 - 05/2004
4Indicators and Reagents (Reagents)IBA
10/2021 - 07/2005
4Conditioned Culture MediaIBA
01/2021 - 01/2013
4p38 Mitogen-Activated Protein KinasesIBA
01/2020 - 10/2013
4Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
01/2019 - 05/2003
4Nucleic AcidsIBA
01/2019 - 07/2007
4Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA
07/2016 - 12/2002
4Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
11/2015 - 08/2006
4Ganciclovir (Cytovene)FDA LinkGeneric
06/2014 - 07/2012
4Doxorubicin (Adriamycin)FDA LinkGeneric
07/2012 - 01/2006
4A-Form DNA (A-DNA)IBA
04/2005 - 12/2002
3Glucose (Dextrose)FDA LinkGeneric
08/2022 - 01/2019
3Cisplatin (Platino)FDA LinkGeneric
03/2022 - 12/2018
3Long Noncoding RNAIBA
03/2022 - 05/2017
3Tuberculin (PPD)IBA
01/2022 - 01/2016
3Neutralizing AntibodiesIBA
01/2022 - 01/2016
3Anti-Bacterial Agents (Antibiotics)IBA
01/2022 - 10/2019
3Interleukin-18 (Interleukin 18)IBA
11/2021 - 07/2003
3Protein Isoforms (Isoforms)IBA
10/2021 - 06/2016
3Glycoproteins (Glycoprotein)IBA
01/2021 - 01/2020
3oxidized low density lipoproteinIBA
01/2020 - 05/2015
3LipopolysaccharidesIBA
01/2019 - 11/2015
3Zinc Finger E-box-Binding Homeobox 1IBA
01/2018 - 01/2017
3Therapeutic UsesIBA
10/2017 - 06/2014
3Calcitriol Receptors (Calcitriol Receptor)IBA
03/2017 - 10/2012
3T0901317IBA
01/2016 - 04/2014
3Liver X ReceptorsIBA
01/2016 - 04/2014
3Antineoplastic Agents (Antineoplastics)IBA
11/2015 - 06/2014
3InterferonsIBA
02/2015 - 07/2014
3Green Fluorescent ProteinsIBA
01/2013 - 07/2012
3ProteomeIBA
12/2012 - 11/2004
2Contrast MediaIBA
09/2022 - 01/2022
2ErbB Receptors (EGF Receptor)IBA
07/2022 - 02/2013
2Poly(ADP-ribose) Polymerase InhibitorsIBA
03/2022 - 01/2021

Therapy/Procedure

59Therapeutics
09/2022 - 12/2002
7Drug Therapy (Chemotherapy)
03/2021 - 12/2006
5Immunotherapy
11/2021 - 12/2002
4Oral Administration
07/2022 - 12/2014
3Transplantation
01/2020 - 01/2019